Omid Hamid, MD, The Angeles Clinic and Research Institute, Los Angeles, CA, discusses upcoming research in skin cancer, focusing on non-melanoma skin cancer. Dr Hamid highlights current research into anti-CTLA-4 therapies, the aim of which is to use higher doses with less toxicity to achieve better survival outcomes for patients. This interview took place at the American Association for Cancer Research Annual Meeting in New Orleans, LA.
